The Grieving Brain: The Science of Love and Loss
Our guest Dr. Mary-Frances O’Connor is a renowned grief expert, author, neuroscientist, and an associate professor of psychology at the…
Blog - Melanoma360
01/11/2023
The Grieving Brain: The Science of Love and Loss
Our guest Dr. Mary-Frances O’Connor is a renowned grief expert, author, neuroscientist, and an associate professor of psychology at the…
|
12/23/2022
AIM at Melanoma Earns a Four-Star Rating From Charity Navigator
December 21, 2022 (Richmond, California) AIM at Melanoma is proud to announce that its strong financial health and ongoing accountability…
|
12/19/2022
The Future of Melanoma Treatment: 2023 and Beyond
Melissa Wilson, PA-C, MPAS from UPMC Hillman Cancer Center, and Vernon Sondak, MD, Chair, Department of Cutaneous Oncology, Moffitt Cancer…
|
12/08/2022
Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update
December 07, 2022 07:00 ET | Source: Replimune Group Inc RP1 combined with nivolumab continues to demonstrate deep and durable responses in…
|
|
11/16/2022
How’s it Growing?
AIM at Melanoma is honored to have been selected by the Matthew Hill Foundation to be a benefitting charity in…
|
11/16/2022
President’s Letter | November 2022
From the Desk of Samantha Guild November is the month to prioritize our gratitude, and I never tire of this…
|
11/16/2022
The Importance of Having a Will
It started with a 13-year melanoma survivor letting us know that he had put us in his will. Jeff Berg,…
|
11/16/2022
In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma
By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
|
11/11/2022
Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
(November 07, 2022 08:01 ET | Source: Iovance Biotherapeutics, Inc. ) Clinically Meaningful and Durable Activity in Largest Cell Therapy…
|
|
11/08/2022
Living Beyond Melanoma: A Conversation with Stage IV Melanoma Survivor, Stephanie Bowen
In this episode, Melissa Wilson, PA-C, MPAS, AIM’s “Ask a Medical Expert” and host of the webinar series, “From the…
|
